Finally, SGK3 depletion leads to elevated NOTCH1 levels and elevated NOTCH1 target gene expression in skin cancer cells, suggesting that SGK3 might act as a negative regulator in contexts in which NOTCH1 is a tumor suppressor, such as during skin tumorigenesis (Wan et al, 2020). This evidence concerns the gene NOTCH1 and neoplasm.